Harald Junge News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ -- AntlerA has applied its next generation programmable ANT platform to develop therapeutics for treating retinopathies. Blood vessels that supply...

Date Time Researchers develop antibody drug that could treat diabetic retinopathy The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy – a protein to treat disease. Now, a new biologic therapy developed by U of T researchers has potential to reverse a common diabetes complication. A team led by Stéphane Angers, professor and associate dean of research at the Leslie Dan Faculty of Pharmacy, has developed a synthetic antibody as a promising treatment for diabetic retinopathy, which causes blindness and affects about...

Pharmacy U of T researchers develop antibody drug that could treat diabetic retinopathy A team led by U of T researcher Stéphane Angers has developed a synthetic antibody as a promising treatment for diabetic retinopathy, which causes blindness and affects about one third of diabetes patients (photo by Tetra Images via Getty Images) The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy – a protein to treat disease. Now, a new biologic therapy developed by U of T researchers has potential to reverse a common...